PROSTATE CANCER (ADENOCARCINOMA)
Clinical trials for PROSTATE CANCER (ADENOCARCINOMA) explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER (ADENOCARCINOMA) trials appear
Sign up with your email to follow new studies for PROSTATE CANCER (ADENOCARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin d trial aims to strengthen immune system in black men with prostate cancer
Disease control Not yet recruitingThis phase 3 trial tests whether daily vitamin D supplements can improve immune function and quality of life in Black/West African men with prostate cancer who have low vitamin D levels. Researchers will compare men with localized disease to those with advanced cancer, tracking i…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE3 • Sponsor: University of Ilorin Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New combo therapy targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingThis early-stage trial tests a combination of two drugs—docetaxel (chemotherapy) and a radioactive compound called 177Lu-PSMA-I&T—in men with advanced prostate cancer that no longer responds to hormone therapy. The goal is to find the safest dose of docetaxel when used with the r…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE1 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for Hard-to-Treat prostate cancer: drug combo trial launches
Disease control Not yet recruitingThis phase 2 trial tests whether adding mevrometostat to enzalutamide can slow cancer growth in 60 men with metastatic castration-resistant prostate cancer who have already been treated with similar drugs. Participants will take both drugs orally. The main goal is to see how long…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE2 • Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Smarter radiation aims to cut side effects in prostate cancer relapse
Disease control Not yet recruitingThis study tests a personalized radiation approach for men whose prostate cancer has returned after surgery. Using PSMA PET scans, doctors will give higher radiation doses to active cancer spots and lower doses to healthy areas, all in just 5 treatments over two weeks. The goal i…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New program aims to protect cancer Patients' hearts during treatment
Disease control Not yet recruitingThis study looks at whether a special program called Primary Care Connect (PC2) helps cancer survivors who also have conditions like high blood pressure, diabetes, or high cholesterol keep their heart risks under control during cancer treatment. About 266 adults with early-stage …
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug cocktail aims to keep prostate cancer away after surgery
Disease control Not yet recruitingThis study tests whether the drug rezvilutamide, combined with standard hormone therapy, can prevent high-risk prostate cancer from coming back after surgical removal. About 33 participants will take the pills and get injections for up to 2 years. The main goal is to see how many…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a supplement boost prostate cancer treatment?
Disease control Not yet recruitingThis early-phase trial tests whether adding a dietary supplement called LC-K76 to standard hormone therapy is safe for men with metastatic hormone-sensitive prostate cancer. Forty men will receive the supplement plus hormone therapy for 24 weeks, then be followed for another 24 w…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could surgery after hormone therapy beat advanced prostate cancer?
Disease control Not yet recruitingThis study looks at men with advanced prostate cancer that has spread to other parts of the body. After 6 months of hormone therapy, those whose scans show the cancer is well-controlled may either continue hormone therapy alone or also have their prostate removed. The goal is to …
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Glow-in-the-Dark dye could help doctors find hidden prostate cancer
Diagnosis Not yet recruitingThis early trial tests a fluorescent dye called AS1986NS that aims to make prostate cancer cells glow during a biopsy. Ten men with suspected prostate cancer will receive a tiny dose of the dye before their standard biopsy. The main goal is to check that the dye is safe, not yet …
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE1, PHASE2 • Sponsor: Antelope Surgical Solutions, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
Prostate cancer Treatment's hidden cost: study tracks sexual side effects
Symptom relief Not yet recruitingThis study follows 130 men with unfavorable intermediate-risk prostate cancer to see how a combination of targeted radiation (SBRT) and 6 months of hormone therapy (ADT) impacts their sexual function. Researchers measure erectile function before treatment and again after 24 month…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Sponsor: CancerCare Manitoba • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC